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Emerging Problems in Infectious Diseases
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Abstract
Background: The emergence of influenza A/H1N1/2009 is alarming. The severity of previous epidemics suggests that the susceptibility of
the human population to H1N1 is directly proportional to the degree of changes in hemagglutinin/HA and neuraminidase/NA; therefore,
H1N1/2009 and H1N1/2008 were analyzed for their sequence as well as structural divergence.
Methodology: The structural and sequence divergence of H1N1/2009 and H1N1/2008 strains were analyzed by aligning HA and NA amino
acid sequences by using ClustalW and ESyPred3D software. To determine the variations in sites of viral attachment to host cells, a
comparison between amino acid sequences of HA and NA glycosylation sites was performed with NetNGlyc software. The antigenic
divergence was executed by CTL epitope prediction method.
Results: The amino acid homology levels of H1N1/2009 were 20.32% and 18.73% compared to H1N1/2008 for HA and NA genes,
respectively. In spite of the high variation in HA and NA amino acid composition, there was no significant difference in their structures.
Antigenic analysis proposes that great antigenic differences exist between both the viral strains, but no addition of a new site of glycosylation
was observed.
Conclusions: To our knowledge, this is the first report suggesting that the circulating novel influenza virus A/H1N1/2009 attaches to the
same glycosylation receptor sites as its predecessor influenza A/H1N1/2008 virus, but is antigenically different and may have the potential
for initiating a significant pandemic. Our study may facilitate the development of better therapeutics and preventive strategies, as well as
impart clues for novel H1N1 diagnostic and vaccine development.
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Introduction
A global pandemic of swine flu, a new strain of
influenza A virus subtype H1N1, is currently
underway. According to the World Health
Organization (WHO), the epidemic started in early
April and by September 20, 2009, over 318,925 cases
with at least 3,917 deaths (CFR ~1.2%) were reported
globally [1], including 10,233 cases and 315 deaths
in India [2]. H1N1/2009 originated due to triple
reassortment among North American swine (30.6%)
and avian influenza (34.4%), human influenza
(17.5%), and classical swine influenza virus (17.5%)
[3]. Influenza A/H1N1 causes acute febrile
respiratory tract infection by infecting epithelial
respiratory cells. H1N1 continues to circulate and
causes annual epidemics that kill approximately 0.25

to 0.5 million people worldwide [4,5,6,7]. H1N1 has
a unique capacity for genetic variation.
Hemagglutinin (HA) and Neuraminidase (NA) are
two surface glycoproteins of the virus and are the
most important antigens for inducing protective
immunity in the host [8]. The severity of previous
epidemics suggests that susceptibility of the human
population to H1N1 is directly proportional to the
degree of change in HA and NA. Greater change
results in lower herd immunity and higher
susceptibility [9].
We therefore analyzed HA and NA of the novel
circulating influenza A/H1N1/2009 strain and
compared it with its predecessor influenza
A/H1N1/2008 virus for sequence variation as well as
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Figure 1. ClustalW amino acid sequences alignment of HA (a) and NA (b) proteins of influenza H1N1/2009 and its
predecessor H1N1/ 2008.

The amino acid sequences of segment 4 of HA protein (a) and segment 6 of NA protein (b) are shown for the Influenza A/California/08/2009(H1N1) and A/District of Columbia/WRAMC-1154048/2008(H1N1)
viruses as described earlier. Standard single-letter abbreviations for the amino acids are used. The collinear sequences were aligned by online use of ClustalW. Amino acid alignment exhibits non-conservative
substitutions (“ ”), conservative substitutions (“:”) and semi-conservative substitutions (“.”). Conserved regions are represented as (“ ”). There are 20.32% differences in 566 positions.

structural and antigenic divergence for a better
understanding of viral pathogenesis and antigenicity.
Materials and Methods
Sequences used in study
For comparison between circulating 2009 and
2008 strains, we used Influenza A/California/08/2009
[submitted to NCBI by Shu et al. (29 April 2009)
with accession numbers FJ971076 for HA and
FJ966973 for NA] and Influenza A/USA/WRAMC1154048/2008 [submitted to NCBI by Houng et al. (1
Feb 2008) with accession numbers CY038770 for
HA and CY038772 for NA] H1N1 strains. These
sequences were used because A/California/08/2009
was the primary strain that led to the swine flu 2009
pandemic and A/USA/WRAMC-1154048/2008 was
its predecessor H1N1 isolated in 2008.
Sequence divergence
We analyzed the sequence divergence of
H1N1/2009 and H1N1/2008 strains by aligning HA

(Figure 1a) and NA (Figure 1b) amino acid
sequences
by
using
ClustalW
(http://www.ebi.ac.uk/Tools/clustalw2/index.html).
Differentiation in glycosylation pattern
To determine the variation in the sites of viral
attachment to host cells, a comparison between
amino acid sequences of HA and NA glycosylation
sites was performed with NetNGlyc 1.0 software
(http://www.cbs.dtu.dk/services/NetNGlyc/) (Table
1).
Antigenic vitiations
The antigenic divergence between 2009 and 2008
influenza A strains was executed by the CTL epitope
prediction method. The amino acid sequences of HA
and NA were evaluated separately with CTLPred
software (http://www.imtech.res.in/raghava/ctlpred/)
using consensus approach. The predicted antigenic
sites were compared for HA and NA, respectively
(Table 2).
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Figure 2. Structural comparison of HA and NA of 2009 and 2008 strains of influenza A/H1N1.

Amino acid sequences were submitted to ESyPred3D software to derive structures for the HA and NA protein for both isolates A/California/08/2009(H1N1) and A/District of
Columbia/WRAMC-1154048/2008(H1N1). The obtained PDB files were visualized by RasMol 2.7.5 and secondary structures are compared as shown in the figure. The obtained structure
of both the proteins has been also shown in the figure. Both the PDB files of 2009 and 2008 strains for HA and NA proteins were submitted to CE server for structural deviation. The
structural alignment and the alignment characteristics are presented in the figure.

Structural divergence
To determine the structural divergence in HA and
NA proteins, the amino acid sequences of HA and
NA were independently analyzed with ESyPred3D
software
(http://www.fundp.ac.be/sciences/biologie/urbm/bioi
nfo/esypred/). Deviations between obtained structures
were calculated (http://cl.sdsc.edu/ce/ce_align.html)
considering high sequence similarity (Figure 2).
Structures were visualized by RasMol 2.7.5.
Secondary structures of both proteins from both
isolates were compared.
Results
The most abrupt changes in antigenic specificity
occurred through the HA and NA genes. Analysis
exhibited an overall sequence homology of 79% in
HA and 81% in NA among 2009 and 2008 viral
strains. Our results revealed that the amino acid
homology levels of H1N1/2009 were 20.32%

(conservative 9.89%, semi-conservative 4.95% and
non-conservative substitutions 5.48%) and 18.73%
(conservative 9.15%, semi-conservative 5.32% and
non-conservative 4.26%) compared to H1N1/2008
for HA (Figure 1a) and NA (Figure 1b), respectively.
Secondary structure comparison suggests that the HA
protein of H1N1/2009 (H-bonds: 314; Helices: 9;
turns: 53; and strands: 44) and H1N1/2008 isolates
(H-bonds: 317; Helices: 10; turns: 50; and strands:
44) as well as the NA protein of H1N1/2009 (Hbonds: 222; Helices: 3; turns: 47; and strands: 37)
and H1N1/2008 isolates (H-bonds: 218; Helices: 2;
turns: 45; and strands: 40) have variations. However,
our structural comparison based on CE server
analysis between H1N1/2009 and H1N1/2008
suggests that in spite of high variations in HA and
NA amino acid composition and differences in
secondary structure, there was no significant
difference in their structure (HA; Rmsd = 0.6
angstrom and NA; Rmsd = 1.3 angstrom) (Figure 2).
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Table 1. Comparison of N-glycosylation sites between HA and NA of 2009 and 2008 influenza A/H1N1 strains.
N-glycosylation
Protein

HA

NA

A/H1N1/2009

A/H1N1/2008

Position

Sequence

Position

Sequence

28
40
104
304
498
557

NSTD
NVTV
NGTC
NTSL
NGTY
NGSL

28
40
104
303
497
556
71
176
142

NSTD
NVTV
NGTC
NSSL
NGTY
NGSL
NCSV
NLSK
NHTV

50
58
63
68
88
146
235

NQSV
NNTW
NQTY
NISN
NSSL
NGTI
NGSC

44
58
63
70
88
146
235
434

NNTG
NSTW
NHTY
NNTN
NSSL
NGTV
NGSC
NTTI

The table shows a comparison of predicted N-glycosylation sites in amino acid sequences for segment 4 (HA) and segment 6 (NA) sequences of the isolate A/California/08/2009(H1N1) and
A/District of Columbia/WRAMC-1154048/2008(H1N1). N-glycosylation potential (0.5) is taken as cutoff.
Red colour indicates the differences between N-glycosylation sites of isolates A/California/08/2009(H1N1) and A/District of Columbia/WRAMC-1154048/2008(H1N1)

glycosylation in H1N1/2009 (Table 1); however,
antigenic analysis proposes considerable antigenic
differences between both the viral strains (Table 2).
To our knowledge, this is the first report suggesting
that the circulating virus H1N1 uses the same
glycosylation sites for its attachment to receptors, but
is antigenically different.
Discussion
Considering the penetrance and global spread of
swine flu, the World Health Organization has
declared a world pandemic for the viral illness [10].
Sequence BLAST analysis of HA and NA genes of
2009 viral strains reveals that the closest relatives of
H1N1/2009 are A/Swine/Indiana/P12439/00 and
A/Swine/England/195852/92 [9]. This observation
suggests that somehow these viruses were transported
from the United States of America and the United
Kingdom to Mexico and transmitted to swine. The
present report of the current outbreak suggests that
H1N1/2009 is neither similar to the 1918
pandemic influenza virus (18% different) nor to the
1976 swine flu (12% different) [9,11]. Our amino
acid sequence divergence analysis suggests a large
variation in HA and NA proteins, but most of the
substitutions are conservative and semi-conservative.
We therefore have not observed any significant
difference in the structure of HA and NA proteins, a

finding which highlights the large structural
flexibilities of HA and NA proteins. Contrary to
H1N1/2009, the most successful pandemic influenza
viruses have retained the core proteins of the virus
and changed only HA and NA.
There is no difference in glycosylation sites
between the presently circulating virus and
H1N1/2008. Glycosylation of HA and NA represent
the characteristic of the pathogen to escape the host
defense through co-evolution with the host and
identification of the host receptor [12]. Our antigenic
analysis shows that H1N1 strains of 2009 and 2008
have large differences in antigenicity. This finding
might be correlated with the large penetrance of
H1N1/2009 because this strain has novel
antigenicity; therefore, the human population lacks
herd immunity [8]. High variation in amino acid
sequences and the unique antigenicity of H1N1/2009
suggest that although the virus infection currently is
not severe, it has further pandemic potential [9,13].
Developing countries have higher risk of infection,
circulation for a longer time period, and further
pandemic evolution [13]. Co-infections during bouts
of influenza might play a crucial role in the evolution
of H1N1 and may cause the development of
resistance to known antivirals. Although the current
strain of H1N1 has low virulence, mortality during
infection has been observed [5].
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Table 2. Comparison of antigenicity between HA and NA of 2009 and 2008 influenza A/H1N1 strains.

Protein

HA

NA

Position
53
157
160
395
437

Antigenicity
A/H1N1/2009
Sequence
KHNGKLCKL
GAKSFYKNL
SFYKNLIWL
KVNSVIEKM
TYNAELLVL

Position
53
156
159
394
436

100
183
250
298
418

YSKDNSVRI
ACHDGINWL
QASYKIFRI
GSNRPWVSF
IRPCFWVEL

14
61
100
365
418

A/H1N1/2008
Sequence
SHNGKLCLL
GESSFYRNL
SFYRNLLWL
KVNSVIEKM
TYNAELLVL
SIAIGIISL
WVNHTYVNI
YTKDNSIRI
NRLRKGFEM
IRPCFWVEL

The table shows a comparison of antigenic sites in the amino acid sequences of HA (segment 4) and NA (segment 6) of isolates A/California/08/2009(H1N1) and A/District
of Columbia/WRAMC-1154048/2008(H1N1).
Red colour indicates the differences between antigenic sequences of isolates A/California/08/2009(H1N1) and A/District of Columbia/WRAMC-1154048/2008(H1N1).

The evolution of H1N1 2009 by triple
reassortment from three different hosts and coinfections with other influenza A viral strains is an
alarming concern because it suggests that the virus is
not only assorting in multiple hosts, but also getting
more chances to reassort in humans. Along with
antigenic shift and antigenic drift, H1N1 may evolve
into a novel influenza A supervirus, which may be
antigenenically unique. It may then transmit as well
as infect and replicate in multiple hosts and may have
resistance to known antivirals; therefore, future
preparedness is mandatory. Long-term preventive
measures should be considered along with short-term
preventions [14]. Apart from viral factors, host
factors may play an important role in influencing the
dynamics of H1N1 infection [15]. Earlier serological
evidence suggests that, due to immunity from prior
exposure to the H2N2 influenza strains before 1900,
the elderly were not affected severely in the 1957
epidemic [16], but because the present influenza
A/H1N1/2009 is a novel strain and has not been
reported earlier, similar antigenic protection is not
anticipated. The lack of pro-human adaptive
molecular markers in the currently circulating strain
suggests the involvement of new determinants
responsible for transmission of the virus to human
and low infection [8]. This virus, therefore, can be
used to study the involvement of new determinants,
which may help us to develop effective vaccines
against lethal H1N1 strains.
Collectively, our results highlight the need for
studies on the evolution of H1N1 immunity, and for
the first time, provide evidence that H1N1/2009 uses
the same glycosylation sites as its predecessor
H1N1/2008 and may have a potential to initiate a

more seriously mortal pandemic, owing to its
antigenic difference with H1N1/2008. Our study may
facilitate the development of better therapeutics and
preventive strategies.
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